Alliances with innovative partners are an integral and essential part of our long-term business and research strategy.
At Sirna Therapeutics Inc., a wholly owned subsidiary of Merck & Co. Inc., we recognize that the greatest achievements are not reached alone, they are a result of teamwork. We have a strong tradition of successful partnerships.
We are teaming up with biotech, drug delivery companies, and universities to accelerate the drug discovery process. Our vision is to create a “virtual lab”—the blending of the best programs from internal research and external collaborations.
Whether you are working for biotechnology, a small to medium-size pharmaceutical company, or an academic institution, we understand that you have unique strengths to identify innovative therapeutic approaches, compounds and technologies. We invite you to explore a combination of your strengths with ours, and the successes we may share. We welcome partnerships that will enhance the productivity of our research laboratories.
|
Sirna is providing a package of siRNA material, protocols and performance criteria under a Material Transfer Agreement (MTA) that companies can access to generate data for Sirna's review. If your company has an interest in obtaining this material to demonstrate the performance of your delivery technology please contact Sirna.
